Vaithinathan Selvaraju

Thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy increased pro-angiogenic factors, reduced fibrosis and improved heart function in the infarcted rat myocardium

Sumanth Suresh, Vaithinathan Selvaraju, Mahesh Thirunavukkarasu et al. · International Journal of Cardiology · 2015 · 57 citations

Inflammation, Regenerative Medicine, Fibrosis +15

Protective effects of Phyllanthus emblica against myocardial ischemia-reperfusion injury: the role of PI3-kinase/glycogen synthase kinase 3β/β-catenin pathway

Mahesh Thirunavukkarasu, Vaithinathan Selvaraju, Leonidas Tapias et al. · Journal of Physiology and Biochemistry · 2015 · 44 citations

Cardiovascular Toxicity, Redox Signaling, Cardiovascular Disease +12

Deletion of prolyl hydroxylase domain proteins (PHD1, PHD3) stabilizes hypoxia inducible factor-1 alpha, promotes neovascularization, and improves perfusion in a murine model of hind-limb ischemia

Muhammad Tipu Rishi, Vaithinathan Selvaraju, Mahesh Thirunavukkarasu et al. · Microvascular Research · 2014 · 38 citations

Inflammation, Molecular Physiology, Biochemistry +14

Ethnic variability associating gut and oral microbiome with obesity in children

Baskar Balakrishnan, Vaithinathan Selvaraju, Jun Chen et al. · Gut Microbes · 2021 · 35 citations · Full text

Glutaredoxin-1 Overexpression Enhances Neovascularization and Diminishes Ventricular Remodeling in Chronic Myocardial Infarction

Ram Sudheer Adluri, Mahesh Thirunavukkarasu, Lijun Zhan et al. · PLoS ONE · 2012 · 34 citations · Full text